1999
DOI: 10.1159/000023351
|View full text |Cite
|
Sign up to set email alerts
|

Evidence for the Synthesis of Corticosteroid-Binding Globulin in Human Placenta

Abstract: We demonstrated the expression of corticosteroid-binding globulin (CBG) in human placenta using reverse transcription-polymerase chain reaction-Southern blot analysis and immunohistochemical and immunoblotting studies. In the RT-PCR-Southern blot analysis, only one predicted PCR product was detected without nonspecific products in all samples of human placenta and 3A (tPA-30-1) human placental cells. In Western blot analysis, polyclonal anti-CBG antibodies recognized a protein of approximately 55 kD in the pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
15
0

Year Published

2001
2001
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 35 publications
(35 reference statements)
1
15
0
Order By: Relevance
“…CBG may be narrowly expressed in human tissues, with definite tissue expression demonstrated in hepatocytes and in placental syncytiotrophoblasts (24) where CBG may modulate glucocorticoid and progesterone tissue interactions (2). CBG has been reported in rodent adipose tissue by corticosterone binding but not gene expression (11,12), and this may represent circulating CBG from plasma taken into cells.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…CBG may be narrowly expressed in human tissues, with definite tissue expression demonstrated in hepatocytes and in placental syncytiotrophoblasts (24) where CBG may modulate glucocorticoid and progesterone tissue interactions (2). CBG has been reported in rodent adipose tissue by corticosterone binding but not gene expression (11,12), and this may represent circulating CBG from plasma taken into cells.…”
Section: Discussionmentioning
confidence: 99%
“…A negative control, with no reverse transcriptase added, was included for each RNA sample. Previously published CBG (24) and GAPDH (8) primer sequences and a second set of CBG primers we designed (sense 5Ј-GACAAGGGGAAGATGAACAC-3Ј, antisense 5Ј-GCACAGCTTTATGGACCAC-3Ј) were obtained commercially. The PCR was performed in a Corbett Research PC-90 microplate thermal sequencer with an annealing temperature of 55°C and 2 mM MgCl2, these parameters having been optimized for the primers by use of HepG2 cDNA as the positive control.…”
Section: Methodsmentioning
confidence: 99%
“…Female pups have higher circulating concentrations of CBG resulting in decreased corticosterone negative feedback upon immune and HPA function relative to male pups (McCormick et al 2002;Shanks et al 1994). In the human placenta, cortisol bioavailability is probably controlled by 11β-HSD 2 activity (Patel et al 1999) and possibly CBG (Dancis et al 1978;Misao et al 1999;Benassayag et al 2001). However, no sex-specific differences are known in placental CBG.…”
Section: Sex-specific Differences Of Fetal Immunitymentioning
confidence: 99%
“…We also measured the binding properties of CBG before and after removal of endogenous ligands to assess the influence of the steroid and lipid environments in each compartment on the CBG be- havior. Finally, we used reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting to test the capacity of trophoblastic cells from human term placenta to produce CBG mRNA and protein [17].…”
Section: Introductionmentioning
confidence: 99%